These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23572128)

  • 1. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study.
    Kaneko J; Sugawara Y; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
    Transplantation; 2013 May; 95(9):1142-7. PubMed ID: 23572128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios.
    Tajima T; Hata K; Tanaka K; Iyama N; Kusakabe J; Kageyama S; Ogawa E; Okamoto T; Haga H; Uemoto S; Hatano E
    J Hepatobiliary Pancreat Sci; 2024 Jul; 31(7):455-467. PubMed ID: 38845404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
    Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience.
    Wahab MA; Abdel-Khalek EE; Elshoubary M; Yassen AM; Salah T; Sultan AM; Fathy O; Elmorshedi M; Shiha U; Elsadany M; Adly R; Samy M; Shehta A
    Transplant Proc; 2021 Mar; 53(2):636-644. PubMed ID: 33549346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Review of Standardized Incidence Ratio of Nonlymphoid, De Novo Malignancies After Liver Transplant Versus After Kidney Transplant.
    Kim A; Waldron O; Daoud D; Huang Y; Patel J; Hong J; Butler T; Jain A
    Exp Clin Transplant; 2024 Aug; 22(8):600-606. PubMed ID: 39254071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
    Mizuno S; Hayasaki A; Ito T; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2699-2704. PubMed ID: 30401380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Kim KH; Park GC; Kim BS; Park IJ; Lim SB; Kim JC; Yoo MW; Byeon JS; Jung HY; Lee GH; Myung SJ; Choe J; Choi JY; Park HW; Lee SG
    Transplant Proc; 2016; 48(1):145-51. PubMed ID: 26915860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
    Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
    Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo malignancy post-liver transplantation: a single center, population controlled study.
    Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
    Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.
    Johnson EE; Leverson GE; Pirsch JD; Heise CP
    J Gastrointest Surg; 2007 Mar; 11(3):272-9. PubMed ID: 17458597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
    J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.
    Park HW; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Yoon SY; Park CS; Park YH; Lee HJ; Lee SG
    Transplant Proc; 2012 Apr; 44(3):802-5. PubMed ID: 22483500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant malignancy in liver transplantation: a single center experience.
    Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
    Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancy in heart transplant recipients: A single center experience in Japan.
    Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients.
    Barrera FJ; Mostofsky E; Salia S; Lehman L; Liou L; Mucci L; Mittleman MA
    Int J Cardiol; 2024 Nov; 415():132455. PubMed ID: 39153512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.